Top

Cannvas to Attend Extraordinary Future 2018 Conference in Vancouver, BC

Cannvas to Attend Extraordinary Future 2018 Conference in Vancouver, BC

Visit Booth 708 to Meet the Team and Hear the Cannvas Story

TORONTO, Sept. 14, 2018 /CNW/ – Cannvas MedTech Inc. (“Cannvas” or the “Company“) (CSE: MTEC, Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce that its senior management team will be attending Extraordinary Future 2018 on September 19-20 in Vancouver, BC. Extraordinary Future 2018 is an excellent opportunity to showcase Canadian technologies to the investment community. The Cannvas executive team will be available for meetings in Booth #708 where CEO Shawn Moniz and COO Steve Loutskou will be in attendance. Mr. Moniz will also deliver an investor presentation on September 20th at 12:10 pm.

Event:             

Extraordinary Future 2018

Date:              

Thursday, September 20, 2018

Booth:             

#708

Presentation:

12:10 – 12:20pm PT, Workshop 1

Venue:            

Vancouver Convention Centre East, 999 Canada Place, Vancouver, BC

Event Hours:  

9:00am – 6:00pm

Produced by Cambridge House International and held at the Vancouver Convention Centre, the two-day conference focuses on innovative technologies and offers attendees the chance to connect with entrepreneurs, investors, and innovators. The theme of the conference is to explore ideas that will directly impact the “the extraordinary future of science and life.” To that end, topics to be discussed include:

  • Cannabis Delivery Systems
  • Mental Health and Longevity
  • Startup Competition
  • Battery Technology
  • Blockchain & the Music Industry
  • Tokenized Securities
  • Quantum Computing
  • Data Warfare

Extraordinary Future features a tradeshow exhibition, one-on-one meetings with investors, presentations, keynote speakers, and much more.

To register and for more information visit: www.extraordinaryfuture.com.

 

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

 

For additional information:
www.cannvasmedtech.com

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

SOURCE Cannvas MedTech Inc.

For further information: Media Inquiries: media@cannvasmedtech.com; Investor Relations: ir@cannvasmedtech.com, 1-800-489-0116

X